Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by davgroon Apr 27, 2022 11:13am
101 Views
Post# 34635617

RE:this is how fast the market went from green to red

RE:this is how fast the market went from green to red
Duster340 - (4/20/2022 10:39:57 AM) wrote: Another 3K filled @77 maybe get the rest before the close. adding on the dips. expecting some news before the end of the month, also a throwing out a bone to davgro to buy since he has a problem buying in just prior to a stock selling off you have to look no further than his pot stocks. i kind of feel sorry for the little bugger.

Yo Dust Bag, I think you meant to post "this is how fast my investment went from green to red".

Those pennies you are flipping are going right down the sewer grate. ATE sitting at $ 0.67 with no price support at all.  We will probably see a new 52-week low shortly unless management can produce some news of significance and that doesn't include fluff like "Antibe Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference"
<< Previous
Bullboard Posts
Next >>